A-005

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameA-005
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionTyrosine-protein kinase 2 inhibitorsNeuroprotectants
TargetsTyrosine-protein kinase 2
Therapy Area/IndicationsNerve DegenerationParkinson DiseaseMultiple Sclerosis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlumis Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlumis Inc
Inactive CompaniesN/A
Active IndicationsNerve DegenerationParkinson DiseaseMultiple Sclerosis +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A